Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer

NCT06745804 is registered in ClinicalTrials.gov with Radionetics Oncology as lead sponsor.

NCT NCT06745804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06745804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer
Lead sponsor
Radionetics Oncology
Phase
Phase 1
Overall status
Completed
Start date
December 10, 2024
Completion date
May 4, 2026
Enrollment
27 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor positive breast adenocarcinoma, locoregionally recurrent hormone-receptor positive breast cancer, metastatic hormone receptor positive breast cancer